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Abstract

Three newly synthesized benzamides by the Department of Pharmaceutical
Chemistry of the Faculty of pharmacy from the University of Medicine and
Pharmacy „Carol Davila” Bucharest were tested in order to determine whether these
new molecules have similar effects on the central nervous system as those already in
therapeutic use belonging to the same chemical group, such as tiapride (neuroleptic)
or lidocaine (local anaesthetic).
Tests were carried out on NMRI mice which were given new compounds,
conventionally named I5C, I14C, and II5C in a dose of 1/20 of the lethal dose 50%
(LD50), as previously determined. They received this treatment daily for 21 days.
The evasive–investigating capacity of mice was determined using the platform test,
and the motor activity using an Activity cage device.
The results have shown that compounds I5C and II5C decrease the investigation
capacity of the mice; and compound I5C inhibits motor activity, while II5C
stimulates it. Thus we concluded that only compounds I5C and II5C have a
neuroleptic potential that might be investigated further.
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Introduction
Benzamides correspond to a carbonic acid amide of
the benzoic acid. Amide has the general formula RCO-

Group 1 – I5C: 9,82mg/bw (1/20 x LD50)
intraperitoneal injection
Group 2 – I14C: 10,7mg/bw (1/20 x LD50)
intraperitoneal injection

NH2, in such compounds the carbon atom being

Group 3 – II5C: 7,83mg/bw (1/20 x LD50)
attached to oxygen and also a hydroxyl group. intraperitoneal injection
Group 4 – Control: distilled water in similar

Generally, amides are divided into distinct subclasses

according to the number of nitrogen substituents. injection volume.
Mice were kept in an environment with constant
Primary amide results through NH2 replacement of the
o
carboxylic hydroxyl group, and usually it has a higher temperature and relative humidity (22-24 C, 45-60%),
while having free access to food and water. The
boiling point than secondary and tertiary amides. The
chemical structures of the tested compounds are shown
secondary and tertiary amides result when one or both
below (2):
hydrogens are replaced by other groups in primary

Br

amides (1-3).

CO

N

(CH2)2

From the group of benzamides, two active

+
NH(C2H5)2
Cl-

substances have been extensively in use in psychiatry
Cl
Figure 1. Chemical structure of compound I5C

and other related medical fields, namely Sulpiride and
Amisulpiride. Remoxipride is another benzamide that

H3CO

was removed from the market due to life threatening side
effects in 1993 (4-6). Depending on the compound,

H3CO

CO

N

(CH2)2

benzamides have antidepressant activity, anticonvulsant

+
NH(C2H5)2
Cl-

H3CO

activity, anti-inflammatory activity, analgesic properties,
serotonin (5-HT) activity, antitumor activity, and

Cl
Figure 2. Chemical structure of compound I14C

antimicrobial activity (7-8).
The purpose of this study was to identify new

Br

molecules with a higher degree of selectivity on
receptors implicated in neurotransmission that is directly

CO

N

(CH2)2

+
NH(CH3)2
Cl-

involved in the normal psychological functions, but with
Cl
Figure 3. Chemical structure of compound II5C

a lower rate of side effects.

Materials and Methods
A sample of 80 white NMRI mice having reached



Testing investigation–evasion capacity (7).
Each mouse was placed at the center of a circular

maturity, weighing 23±2g, divided in 4 groups, was used platform 20cm in diameter with 2cm high margins
in this study. They were treated for 21 days as follows.

suspended at a 50cm height from the horizontal surface
149
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of a table. The number of times the mouse popped its purposes. All experimental procedures were approved by
head over the margins of the platform in a one minute the Ethical Committee of the Faculty of Pharmacy
time frame was recorded. This test was carried out on
days 3, 7, 14, 21 of the experiment.

Bucharest.


Statistical analysis
Statistical calculation used the software GraphPad



Testing motor activity (7).

Prism 5. Statistical comparison between groups used the
Each mouse was placed in an Autotrackactometer Student t test (for normal distribution) for two groups.
for 1 minute and three parameters were determined: the
Normality of response distribution in collectivity was
distance traveled by the mouse (m), the speed of
tested with the D’Agostino & Pearson test. Figures were
traveling (m/s), and the time spent in the central area of
observation (s). This test was carried out on days 4, 9, made using a Microsoft Office Excel 2013 computer
program.

15, 22 of the experiment.
All experimental procedures were carried out in
accordance with the Directive 2010/63/UE of 22nd

Results

September 2010, regarding the protection of animals The evasion–investigation test yielded the following
used

for

experimental

and

other

scientific results:

Table 1. Dynamics of mouse crossings over the side of the platform
Group/ Day of
determination

Average ± Standard
deviation

D`Agostino
normality test

Effect % vs
Control

t test vs Control
(p value)

Control – D3

6.05 ± 4.45

YES

-

-

Control – D7
Control – D14

4.66 ± 2.93
5.80 ± 3.00

YES
YES

-

-

Control – D21

10.85 ± 5.17

YES

-

-

I5C – D3

4.50 ± 2.11

YES

-25.62%

p>0.05

I5C – D7

4.65 ± 2.77

YES

-3.58%

p>0.05

I5C – D14

6.20 ± 3.10

YES

+6.9%

p>0.05

I5C – D21

5.95 ± 3.12

YES

-45.16%

p<0.001

I14C – D3

6.40 ± 2.87

YES

+5.78%

p>0.05

I14C – D7
I14C – D14

4.55 ± 3.56
5.65 ± 3.71

YES
YES

-2.51%
-2.59%

p>0.05
p>0.05

I14C – D21
II5C – D3
II5C – D7

7.95 ± 4.44
5.50 ± 3.31
6.00 ± 3.65

YES
YES
YES

-26.73%
-9.09%
+28.56%

p>0.05
p>0.05
p>0.05

II5C – D14
II5C – D21

6.15 ± 3.77
5.90 ± 4.46

YES
YES

+6.03%
-45.62%

p>0.05
p<0.01
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Figure 4. Effect dynamics of 3 benzamides over the
course of the experiment versus Control in the
investigation-evasion test

Compounds I5C and II5C proved to have a negative
impact on the evasion–investigation capacity of mice,

Figure 5. Travelled distance dynamics inside the
actometer over the course of the experiment
versus Control conditions

statistically significant. The motor activity test
yielded the following results:

especially after long term exposure when results became

Table 2. Evolution of the average travelled distance (measured in meters) inside the actometer
Group/ Day of
Average ±
D`Agostino
Effect % vs
t test vs Control
determination
Standard
normality test
Control
(p value)
deviation
Control – D4
6.42 ± 0.93
YES
Control – D9

6.60 ± 1.83

YES

-

-

Control – D15

5.91 ± 1.11

YES

-

-

Control – D22

6.60 ± 1.22

YES

-

-

I5C – D4
I5C – D9
I5C – D15
I5C – D22
I14C – D4

5.68 ± 0.85
6.14 ± 0.44
5.83 ± 0.99
5.82 ± 1.29
6.31 ± 1.01

YES
YES
YES
YES
YES

-11.45%
-7.01%
-1.35%
-11.82%
-1.64%

p<0.01
p>0.05
p>0.05

I14C – D9
I14C – D15
I14C – D22
II5C – D4
II5C – D9

6.57 ± 0.75
5.71 ± 1.43
6.45 ± 0.80
11.0 ± 3.57
6.32 ± 0.74

YES
YES
YES
YES
YES

-0.44%
-3.35%
-2.27%
+71.34%
-4.36%

p>0.05
p>0.05
p>0.05
p<0.0001
p>0.05

II5C – D15
II5C – D22

6.30 ± 0.94
7.77 ± 1.41

YES
YES

+6.7%
+17.76%

p>0.05
p<0.05

p<0.05
p>0.05
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Table 3. Evolution of the average traveled speed (measured in meters/second) inside the actometer
Group/ Day of
determination

Average ± Standard
deviation

D`Agostino
normality
test

Effect % vs
Control

t test vs Control

Control – D4

0.11 ± 0.02

YES

-

-

Control – D9

0.11 ± 0.03

YES

-

-

Control – D15

0.10 ± 0.02

YES

-

-

Control – D22

0.11 ± 0.02

YES

-

-

I5C – D4

0.09 ± 0.01

YES

-12.78%

p<0.05

I5C – D9

0.10 ± 0.01

YES

-9.15%

p>0.05

I5C – D15

0.10 ± 0.01

YES

+0.39%

p>0.05

I5C – D22

0.10 ± 0.02

YES

-12.31%

p<0.05

I14C – D4

0.11 ± 0.02

YES

-2.55%

p>0.05

I14C – D9

0.12 ± 0.01

YES

-1.44%

p>0.05

I14C – D15

0.10 ± 0.03

YES

-2.22%

p>0.05

I14C – D22

0.11 ± 0.01

YES

-1.97%

p>0.05

II5C – D4

0.19 ± 0.06

YES

+73.18%

p<0.001

II5C – D9

0.11 ± 0.01

YES

-6.36%

p>0.05

II5C – D15

0.11 ± 0.01

YES

+8.42%

p>0.05

II5C – D22

0.14 ± 0.03

YES

+17.52%

p<0.05

(p value)
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Table 4. Evolution of the average time (measured in seconds) spent in the center of the actometer
t test vs
Control

Average ±
Standard
deviation

D`Agostino
normality
test

Effect %
vs.
Control

(p value)

Control – D4

12.51 ± 3.77

YES

-

-

Control – D9

12.35 ± 3.18

YES

-

-

Control – D15

10.29 ± 3.71

YES

-

-

Control – D22

8.81 ± 3.27

YES

-

-

I5C – D4

10.31 ± 3.12

YES

-17.59%

p<0.05

I5C – D9

10.33 ± 3.36

YES

-16.36%

p>0.05

I5C – D15

8.97 ± 3.50

YES

-12.78%

p>0.05

I5C – D22

7.62 ± 4.89

YES

-13.51%

p>0.05

I14C – D4

12.03 ± 3.36

YES

-3.84%

p>0.05

I14C – D9

10.35 ± 2.80

YES

-16.19%

p<0.05

I14C – D15

8.60 ± 3.16

YES

-16.37%

p>0.05

I14C – D22

8.53 ± 3.89

YES

-3.18%

p>0.05

II5C – D4

12.32 ± 3.61

YES

-1.52%

p>0.05

II5C – D9

9.36 ± 2.43

YES

-24.15%

p<0.05

II5C – D15

8.74 ± 2.95

YES

-15.01%

p>0.05

II5C – D22

10.87 ± 3.13

YES

23.38%

p<0.05

Group/ Day of determination

treatment of various forms of psychosis, but it also

Discussion
Benzamides

are

a

well

known

class

of

pharmacological agents with multiple uses in managing
a wide range of nervous and psychic disorders. Tiapride,

induces unpleasant side effects such as dizziness,
headaches, tremor, dystonia, akathisia (4-6).
The biological activities examined by several

for instance, is used as an antipsychotic drug because it studies in organic scaffolds are therefore related to the
inhibits the D2 dopaminergic receptors, but it also has pharmacological class of benzamides systems. Such
an indirect analgesic effect by activating the 5HT1 and biological activities are generally obtained through
5HT2 serotoninergic receptors (1-3). Sulpiride is substitutions on benzamide either by the aliphatic,
another well-known example of an antipsychotic drug aromatic,

or heteroaromatic path. In fact

most

with a similar mechanism that is effective in the substituted benzamides manifest bioactive properties, so
153
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they

should

be

viewed

as

possible

medicinal

compounds.

Compound I5C induced a statistically significant
decrease in motor activity, suggesting a sedative type of

In our study, compound II5C induced a statistically
significant increase in motor activity (distance and

antipsychotic profile.
Compound II5C induced a statistically significant

speed) after 4 days of treatment (+71.34% and increase in motor activity, suggesting a possible incisive
+73.14%) and after 22 days of treatment (+17.76% and type of neuroleptic profile.
+17.52%).

Further studies are necessary in order to confirm

Compound I5C induced a statistically significant these preliminary findings.
decrease in motor activity (distance and speed) after 4
days of treatment (-11.45% and -12.78%) and after 22

References
1. Donnier-Maréchal M, Carato P, Larchanché PE,

days of treatment (-11.82% and -12.31%).

Ravez S, Boulahjar R, Barczyk A, Oxombre B,

After 9 days of treatment, compound II5C yielded a

Vermersch

P,

Melnyk

P.

statistically significant decrease in the time spent in the

pharmacological

central area of the actometer (-24.15%), but after 22

derivatives

days of treatment, the same compound resulted in a

protein

statistically significant increase of the same parameter

138:

(+23.38%), possibly a sign of anxiety decrease.

10.1016/j.ejmech.2017.07.014

as

Synthesis

evaluation
potent

ligands.
964-978.

Eur

and
J

PMID:

of

benzamide

selective
Med

and

Chem.

28756263,

sigma-1
2017;
DOI:

2. Chiriță C, Cristea AN, Militaru M, Negreș S,
Compound I5C yielded a decrease in the time spent

Zbârcea CE, Nuță DC. Pharmacological evaluation

in the central area of the actometer over the course of

of acute and subacute toxicity and antidepressant

the experiment, but this was statistically significant only

effect after acute administration of novel N-

at the 4th day of the experiment.

substituted benzamides. Farmacia 2010; 58(1): 2128.

Conclusions
The lack of effective treatment for many psychiatric
diseases and the side effect complexity of many current

3. Tokumaru K, Ito Y, Nomura I, Nakahata T, Shimizu
Y, Kurimoto E, Aoyama K, Aso K. Design,

drugs used for this purpose justify the need for medical

synthesis, and pharmacological evaluation of 4-

research to find new alternatives (9).

azolyl-benzamide derivatives as novel GPR52
agonists.

After performing two specific tests relevant for the
normal functioning of the central nervous system, our
findings revealed the following:
Compounds

and

Chem.

2017;

25(12):

3098-3115. PMID: 28433511,
DOI: 10.1016/j.bmc.2017.03.064
4. Xie R, Yao Y, Tang P, Chen G, Liu X, Yun F,
Cheng C, Wu X, Yuan Q. Design, synthesis and

evasion–

biological evaluation of novel hydroxamates and 2-

investigation capacity of mice (-45.16% and -45.62%),

aminobenzamides as potent histone deacetylase

suggesting an intense central effect.

inhibitors and antitumor agents. Eur J Med Chem.

significant

II5C

Med

a

statistically

I5C

Bioorg

manner

decreased
the

in

154

Cornel Chiriță et al.

2017;

134:

1-12.

PMID:

28391133,

DOI:

10.1016/j.ejmech.2017.03.038

(tri-fluoro- meth- yl) phen- yl] benzamide. Acta
Crystallogr E Crystallogr Commun. 2016; 72(6):

5. Tumer TB, Onder FC, Ipek H, Gungor T,
Savranoglu S, Tok TT, Celik A, Ay M. Biological

819-23. PMID: 27308050,
DOI: 10.1107/S2056989016007866

evaluation and molecular docking studies of nitro 8. Wang J, Omori IM, Fenton M, Soares B: Sulpiride
benzamide derivatives with respect to in vitro anti-

augmentation for schizophrenia. Schizophr Bull.

inflammatory activity. Int Immunopharmacol. 2017;

2010; 36(2): 229-30.

43:

129-139.

PMID:

27988460,

DOI: 9. Moagar-Poladian

10.1016/j.intimp.2016.12.009
6. Peter DH, Fahlads D. Tiapride – Review of its
pharmacology. Drugs 1994; 47(6): 1010-1032.
7. Suchetan PA, Suresha E, Naveen S, Lokanath NK.

S,

Folea

V,

Paunica

M.

Competitiveness of EU member states in attracting
EU funding for research and innovation. Romanian
Journal of Economic Forecasting. 2017; 20(2): 150167.

Crystal structures of 3-fluoro-N-[2-(tri-fluoro-methyl)phen-yl]benzamide,

3-bromo-N-[2-(tri-fluoro-

meth-yl) phen- yl]benzamide and 3-iodo- N- [2-

155

